STAT3 and hepatocellular carcinoma: Furthermore, it was demonstrated that administering CuI to HepG2 hepatocellular carcinoma cells decreases the number of proteins in the PI3K/AKT/mTOR, MAPK, and JAK2/STAT3 cascades.